Related references
Note: Only part of the references are listed.Meta-analysis of recurrence pattern after resection for pancreatic cancer
M. Tanaka et al.
BRITISH JOURNAL OF SURGERY (2019)
Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8th edition of the American Joint Committee on Cancer staging system
Hong-Yu Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy
Daisaku Yamada et al.
SURGERY TODAY (2018)
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer
Stijn van Roessel et al.
JAMA SURGERY (2018)
pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma
Anna Melissa Schlitter et al.
EUROPEAN JOURNAL OF CANCER (2017)
Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention
Kyohei Ariake et al.
SURGERY TODAY (2017)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for Tand N Staging in Patients With Pancreatic Adenocarcinoma
Peter J. Allen et al.
ANNALS OF SURGERY (2017)
Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis
Sivesh K. Kamarajah et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant
Burcu Saka et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Revisiting the Concept of Lymph Node Metastases of Pancreatic Head Cancer: Number of Metastatic Lymph Nodes and Lymph Node Ratio According to N Stage
Mee Joo Kang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The Epidemiology of Pancreatitis and Pancreatic Cancer
Dhiraj Yadav et al.
GASTROENTEROLOGY (2013)
N0/N1, PNL, or LNR? The Effect of Lymph Node Number on Accurate Survival Prediction in Pancreatic Ductal Adenocarcinoma
Nakul P. Valsangkar et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Pancreatic Cancer Death Rates by Race Among US Men and Women, 1970-2009
Jiemin Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Incidence, Prognosis, and Possible Treatment Strategies of Peritoneal Carcinomatosis of Pancreatic Origin A Population-Based Study
Irene Thomassen et al.
PANCREAS (2013)
Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
N. Volkan Adsay et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2012)
Arterial Resection During Pancreatectomy for Pancreatic Cancer A Systematic Review and Meta-Analysis
Nathan Mollberg et al.
ANNALS OF SURGERY (2011)
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer
Timothy M. Pawlik et al.
SURGERY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Predicting survival after surgical resection for pancreatic ductal adenocarcinoma
HJ Moon et al.
PANCREAS (2006)